Stephen Machatha

ALDX

Stephen Machatha serves as Chief Development Officer at Aldeyra Therapeutics, Inc. (ALDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$288.3K

Net Position

Net Seller

$288.3K

Companies Traded

ALDX

Active Period

Mar 2024 – Aug 2025

3 total trades

Most Recent

Sell ALDX

Aug 11, 2025 · $113.7K

Stephen Machatha's Insider Trading at Aldeyra Therapeutics, Inc. (ALDX)

Buys

0 · $0.00

Sells

3 · $288.3K

Total Shares Bought

Total Shares Sold

67,882

ALDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Aug 11, 2025	Sell	22,073	$5.15	$113.7K
Aug 12, 2024	Sell	16,041	$4.74	$76.0K
Mar 9, 2024	Sell	29,768	$3.31	$98.6K

Related Insiders

DOUGLAS RICHARD

director

ALDXBuy · Mar 20, 2026

Michael Alfieri

Principal Financial Officer

ALDXBuy · Mar 19, 2026

Explore More Insider Trading Data

ALDX Insider Trading Activity

View all insider trades at Aldeyra Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity